An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus an aminoglycoside + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial-an update to the published protocol.
Trials
; 25(1): 457, 2024 Jul 05.
Article
in En
| MEDLINE
| ID: mdl-38970065
ABSTRACT
This article reports an update to the protocol of the IMASOY trial, which was prospectively registered on clinicaltrials.gov (NCT04110340) in October 2019.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ciprofloxacin
/
Anti-Bacterial Agents
Limits:
Animals
/
Humans
Language:
En
Journal:
Trials
/
Trials (Online)
Journal subject:
MEDICINA
/
TERAPEUTICA
Year:
2024
Document type:
Article
Affiliation country:
Madagascar
Country of publication:
United kingdom